Eisler Capital (US)’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
$15.1M Buy
17,100
+3,100
+22% +$2.79M 0.32% 79
2024
Q2
$12.7M Buy
14,000
+9,200
+192% +$7.36M 0.23% 98
2024
Q1
$3.73M Buy
+4,800
New +$3.42M 0.09% 204
2023
Q4
Sell
-25,100
Closed -$13.5M 350
2023
Q3
$13.5M Buy
25,100
+6,900
+38% +$3.56M 0.34% 61
2023
Q2
$8.54M Buy
+18,200
New +$7.63M 0.3% 64

Other funds holding LLY

Eisler Capital (US)'s LLY Position: Q3 2024 in Review

Eisler Capital (US) opened a new position in Eli Lilly (LLY) in Q3 2024: 2,975 shares worth $2.64M. The stake represents 0.06% of the portfolio and ranks #289 among its holdings.

3,659 funds tracked by Wall St. Rank hold LLY as of Q3 2024.

  • Eisler Capital (US) held 2,975 shares of Eli Lilly worth $2.64M as of Q3 2024.
  • Eli Lilly was a new Eisler Capital (US) position in Q3 2024.
  • Eli Lilly made up 0.06% of Eisler Capital (US)'s portfolio in Q3 2024, its #289 holding.
  • 3,659 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2024.

Based on Eisler Capital (US)'s 13F filing for Q3 2024, filed 14 Nov 2024.